NO981965L - Trombininhibitorer - Google Patents

Trombininhibitorer

Info

Publication number
NO981965L
NO981965L NO981965A NO981965A NO981965L NO 981965 L NO981965 L NO 981965L NO 981965 A NO981965 A NO 981965A NO 981965 A NO981965 A NO 981965A NO 981965 L NO981965 L NO 981965L
Authority
NO
Norway
Prior art keywords
thrombin inhibitors
thrombin
inhibitors
Prior art date
Application number
NO981965A
Other languages
English (en)
Norwegian (no)
Other versions
NO981965D0 (no
Inventor
Anton Egbert Peter Adang
Constant Adriaan Anton Boeckel
Peter Diederik Jan Grootenhuis
Jacobus Albertus Maria Peters
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO981965D0 publication Critical patent/NO981965D0/no
Publication of NO981965L publication Critical patent/NO981965L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO981965A 1995-11-03 1998-04-30 Trombininhibitorer NO981965L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95202982 1995-11-03
EP95203554 1995-12-19
PCT/EP1996/004785 WO1997017363A1 (en) 1995-11-03 1996-10-30 Thrombin inhibitors

Publications (2)

Publication Number Publication Date
NO981965D0 NO981965D0 (no) 1998-04-30
NO981965L true NO981965L (no) 1998-06-30

Family

ID=26139759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981965A NO981965L (no) 1995-11-03 1998-04-30 Trombininhibitorer

Country Status (23)

Country Link
US (2) US6432921B2 (pt)
EP (1) EP0858464B1 (pt)
JP (1) JPH11515033A (pt)
KR (1) KR19990067219A (pt)
CN (1) CN1202902A (pt)
AR (1) AR004254A1 (pt)
AT (1) ATE239755T1 (pt)
AU (1) AU712940B2 (pt)
BR (1) BR9611377A (pt)
CA (1) CA2235586A1 (pt)
CZ (1) CZ133998A3 (pt)
DE (1) DE69628027T2 (pt)
DK (1) DK0858464T3 (pt)
ES (1) ES2199302T3 (pt)
HU (1) HUP9900728A3 (pt)
IL (1) IL119466A (pt)
NO (1) NO981965L (pt)
PL (1) PL326863A1 (pt)
PT (1) PT858464E (pt)
RU (1) RU2178796C2 (pt)
TR (1) TR199800773T2 (pt)
TW (1) TW486459B (pt)
WO (1) WO1997017363A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121474A0 (en) * 1996-08-23 1998-02-08 Akzo Nobel Nv Thrombin inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
CA2268281A1 (en) * 1996-10-11 1998-04-23 Cor Therapeutics, Inc. Selective factor xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
JP2002513412A (ja) 1997-04-14 2002-05-08 シーオーアール セラピューティクス インコーポレイテッド 選択的Xa因子阻害剤
AU6896298A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
AU6896398A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
EP0884325A1 (en) * 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
US5877156A (en) * 1997-04-24 1999-03-02 Akzo Nobel, N.V. Thrombin inhibitors
BR9809342A (pt) * 1997-05-02 2000-07-04 Akzo Nobel Nv Composto, composição farmacêutica, e, uso do composto
WO1998051684A1 (en) 1997-05-15 1998-11-19 Eli Lilly And Company Antithrombotic compound
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
SK10742001A3 (sk) 1999-01-27 2002-08-06 Ortho-Mcneil Pharmaceutical, Inc. Peptidylové heterocyklické ketóny použiteľné ako inhibítory tryptázy
US6344450B1 (en) * 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
US7405210B2 (en) * 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ATE483708T1 (de) 2004-03-08 2010-10-15 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
ATE480561T1 (de) 2004-10-19 2010-09-15 Lonza Ag Verfahren zur festphasen-peptidsynthese
ATE424821T1 (de) 2004-12-02 2009-03-15 Prosidion Ltd Pyrrolopyridin-2-karbonsäureamide
CA2651762A1 (en) 2006-05-23 2007-11-29 Irm Llc Compounds and compositions as channel activating protease inhibitors
MX2009008518A (es) 2007-02-09 2009-08-20 Irm Llc Compuestos y composiciones como inhibidores de la proteasa activadora de canal.
SG187271A1 (en) * 2011-07-07 2013-02-28 Agency Science Tech & Res Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic
DK3204352T3 (da) 2014-10-06 2020-09-28 Cortexyme Inc Hæmmere af lysin-gingipain
JP6877424B2 (ja) 2015-11-09 2021-05-26 コーテクシーミー, インコーポレイテッド アルギニンジンジパインの阻害剤
AU2017326466B2 (en) 2016-09-16 2021-11-11 Lighthouse Pharmaceuticals, Inc. Ketone inhibitors of lysine gingipain
ES2907590T3 (es) * 2017-05-25 2022-04-25 Jw Pharmaceutical Corp Método para preparar un derivado heterocíclico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD970253A (ro) * 1994-12-22 1999-05-31 Biochem Pharma Inc. Inhibitori biciclici micromoleculari ai trombinei
US5827860A (en) * 1995-06-07 1998-10-27 Ortho Pharmaceutical Corporation Peptidyl heterocycles useful in the treatment of thrombin related disorders
US5827866A (en) * 1995-06-07 1998-10-27 Ortho Pharmaceutical Corporation Peptidyl heterocycles useful in the treatment of thrombin related disorders
US5523308A (en) * 1995-06-07 1996-06-04 Costanzo; Michael J. Peptidyl heterocycles useful in the treatment of thrombin related disorders

Also Published As

Publication number Publication date
KR19990067219A (ko) 1999-08-16
IL119466A (en) 2001-08-26
NO981965D0 (no) 1998-04-30
IL119466A0 (en) 1997-01-10
CN1202902A (zh) 1998-12-23
EP0858464A1 (en) 1998-08-19
DE69628027D1 (en) 2003-06-12
DK0858464T3 (da) 2003-08-25
EP0858464B1 (en) 2003-05-07
US20020142967A1 (en) 2002-10-03
ES2199302T3 (es) 2004-02-16
AU712940B2 (en) 1999-11-18
CA2235586A1 (en) 1997-05-15
BR9611377A (pt) 1999-02-23
TW486459B (en) 2002-05-11
HUP9900728A2 (hu) 1999-08-30
TR199800773T2 (xx) 1998-08-21
PL326863A1 (en) 1998-10-26
JPH11515033A (ja) 1999-12-21
US20010007764A1 (en) 2001-07-12
CZ133998A3 (cs) 1998-09-16
AU7497596A (en) 1997-05-29
PT858464E (pt) 2003-08-29
WO1997017363A1 (en) 1997-05-15
DE69628027T2 (de) 2004-04-08
AR004254A1 (es) 1998-11-04
HUP9900728A3 (en) 2000-12-28
MX9803479A (es) 1998-09-30
US6432921B2 (en) 2002-08-13
RU2178796C2 (ru) 2002-01-27
ATE239755T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
FI973282A (fi) Trombiinin inhibiittoreita
ATE239755T1 (de) Thrombin inhibitoren
NO20006717D0 (no) Proteaseinhibitorer
DK0869966T3 (da) Prodrugs for thrombin-inhibitorer
FI973360A0 (fi) Uusia dipeptidisiä amidiineja trombiininestäjiksi
FI963597A (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
DE69621026D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
EP0820453A4 (en) THROMBIN INHIBITORS
ID19198A (id) Inhibitor metaloprotease heterosiklik
PT936912E (pt) Inibidores de cisteina protease
NO942064D0 (no) yminhibitorer
ID18416A (id) Inhibitor metaloprotease diheterosiklik
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0956294T3 (da) Thrombininhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
NO974403L (no) Reversible proteasehemmere
BR9610075A (pt) Inibidores prolil endopeptidase
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
ATE282629T1 (de) Thrombininhibitoren
DE69720957T2 (de) Ace-hemmer
BR9610514A (pt) Inibidores cicloantihelmínticos
KR970703937A (ko) 금속단백질 분해효소 억제제(Metallproteinase inhibitors)
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application